AR and hepatocellular carcinoma: To help confirm this pathway, they examined patient tumors to show that AR, CCRK, and ß-catenin were concurrently overexpressed in HCC tumors and that this overexpression was correlated with more advanced tumor stage and lower overall survival [35].